| 產(chǎn)品名稱 | Ciproxifan maleate - FUB 359 maleate |
| 產(chǎn)品貨號(hào) | Axon 1993 CAS [184025-19-2] MF C16H18N2O2.C4H4O4MW 386.40 Purity: 99% Soluble in DMSO Description Orally bioavailable, extremely potent and selective H3-receptor antagonist (Ki: 0.5-1.9 nM in vitro); a potential therapeutic agent in the treatment of Alzheimer's disease References Certificates Categories Extra info X Ligneau et al. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.J. Pharmacol. Exp. Ther. 1998, 287, 658-666. ? ME Bardgett et al. Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease. Neurobiol. Learn. Mem. 2011, 95(1), 64-72.? Certificate of Analysis Material Safety Data Sheet CNS Immunology H3 A18 H3 antagonist Chemical name (4-(3-(1H-imidazol-4-yl)propyl1H-imidazol-4-yl)propoxy)phenyl)(cyclopropyl)methanone maleate Parent CAS No. [184025-18-1] Order Size Unit Price Stock 5 mg €90.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Ciproxifan maleate - FUB 359 maleateAxon 1993 CAS [184025-19-2] MF C16H18N2O2.C4H4O4
Description
Orally bioavailable, extremely potent and selective H3-receptor antagonist (Ki: 0.5-1.9 nM in vitro); a potential therapeutic agent in the treatment of Alzheimer's disease
H3 antagonist
Chemical name(4-(3-(1H-imidazol-4-yl)propyl1H-imidazol-4-yl)propoxy)phenyl)(cyclopropyl)methanone maleate Parent CAS No.[184025-18-1] |
| 產(chǎn)品資料 |
